Operating Lease, Right-of-Use Asset of Turnstone Biologics Corp. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Turnstone Biologics Corp. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
  • Turnstone Biologics Corp. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Turnstone Biologics Corp. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $0 -$1,853,000 -100% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $488,000 -$1,824,000 -79% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $933,000 -$1,833,000 -66% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $1,391,000 -$1,825,000 -57% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,853,000 -$1,849,000 -50% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $2,312,000 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $2,766,000 -$1,865,000 -40% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $3,216,000 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $3,702,000 30 Jun 2023 10-Q 01 Sep 2023 2023 Q2
Q4 2022 $4,631,000 31 Dec 2022 10-K 22 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.